TRUIST FINANCIAL CORP (TFC): what the price requires
At today's price, TRUIST FINANCIAL CORP (TFC) is priced for 11.9% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/TFC
Headline
| Field | Value |
|---|---|
| Ticker | TFC |
| Company | TRUIST FINANCIAL CORP |
| Sector / Industry | Financial Services / Banks—Regional |
| Current price | $51.92/sh |
| Composition | Consumer and Small Business Banking (CSBB) 52% / Wholesale Banking (WB) 48% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | financials |
| Return on equity needed | 11.9% |
| Return on equity now | 8.3% |
| ROE gap | +3.6pp |
| Price-to-book | 1.09x |
Solve inputs: computed at a 11.2% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.1pp.
Reconcile: at the x-ray's 9.3% required return this reads ~9.7%; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +1.68σ |
| cohort percentile (of 119 peers) | 17 |
| sustained it ~10 years at this level | 70% |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.10x | 3 | expensive |
| Earnings | 0.79x | 2 | justifies |
| Relative | 0.62x | 3 | justifies |
| Growth | 0.72x | 3 | justifies |
Families that justify the price: Asset, Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.8%); the inversion above states its own rate.
Per-Model Detail (n=11)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| Bank Fair Value (P/TBV) | — | $29.65 | 1.75x | yes | TBVPS $36.24 × 0.82x (ROE (TTM) 8.6% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 1.55% allowance/loans → ×0.96) |
| Relative Valuation | Relative | $44.50 | 1.17x | yes | P/E 10x (static sector reference · 2026-04), scenarios: 8.5x / 10.0x / 11.5x (bear / base = reference held flat / bull), EV/EBITDA N/Ax |
| Simple DDM | Growth | $344.15 | 0.15x | yes | DPS $2.04, g=8.6% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3% |
| Two-Stage DDM | Growth | $72.24 | 0.72x | yes | Stage 1: 20% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $47.18 | 1.10x | yes | BV/sh $50.70, ROE (TTM) 8.6%, ke 9.3% |
| Two-Stage Excess Return | Asset | $45.51 | 1.14x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $42.93 | 1.21x | yes | Rev $14.5B, growth 2% (input: historical growth; tapered), Terminal P/S: 3.8x / 4.5x / 5.2x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $83.78 | 0.62x | yes | EPS $4.04, growth 21% (input: historical EPS growth), PEG=0.57 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | $67.89 | 0.76x | yes | √(22.5 × EPS $4.04 × BVPS $50.70) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $130.36 | 0.40x | yes | EPS $4.04 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | — |
| PEG Fair Value | Relative | $125.66 | 0.41x | yes | EPS $4.04 × (PEG 1.5 × growth 20.7% (input: historical EPS growth)) → PE 31.1x |
| Earnings Yield | Earnings | $43.68 | 1.19x | yes | EPS $4.04 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Share count CAGR (buyback) | -1.4% |
Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).
Bullet Takeaways
- Truist is one of the largest U.S. regional banks, formed by the BB&T and SunTrust merger, now returning capital aggressively: it paid a 4% dividend yield and raised its 2026 buyback target to $5 billion from $4 billion.
- The biggest issue is that the market pays only about 1.1x book because the bank earns a return that lags peers: recent return on equity is about 8.6%, below what the stock's price ultimately requires.
- Watch net interest margin (3.02% in Q1 2026, down 5 basis points) and the pace of buybacks as CET1 runs down from 10.8% toward the 2027 target of 10%.
Bull Case
The clearest bull signal at Truist is how much capital it is handing back, and where that capital is coming from. Over the trailing year the bank returned $5.77 billion to shareholders, $2.64 billion in dividends and $3.13 billion in buybacks, which is more than its trailing net income of $5.53 billion. That is not reckless; it is a deliberate drawdown of excess capital. The CET1 ratio sits at 10.8%, and management is targeting 10% by 2027, explicitly to free capital for return, and it raised its 2026 buyback target to $5 billion from $4 billion. A bank that can shrink its share count meaningfully while paying a 4% dividend is compounding per-share value for holders who stay.
The buybacks work because the stock is cheap and the earnings are recovering. Q1 2026 net income available to common was $1.4 billion, or $1.09 per share, up 25% year over year, and return on tangible common equity was 13.8%. Buying back stock at roughly 1.1x book, when the underlying tangible returns are near 14%, retires shares at a price that flatters future per-share earnings. The FY2025 10-K shows the earning base is stable and liquid: average consolidated liquidity coverage was "111% for the three months ended December 31, 2025, compared to the regulatory minimum of 100%," and net interest income rose on "loan and deposit growth, fixed-rate asset repricing, and the balance sheet repositioning in the second quarter of 2024."
The franchise itself is the asset. Truist operates a dense southeastern deposit network across some of the fastest-growing U.S. markets, funding a diversified commercial and consumer lending book with a large fee-income engine on top. Having sold its insurance business, the bank now runs a cleaner, capital-rich balance sheet with a clear plan to return the surplus. The bull case is straightforward: a well-capitalized franchise bank, trading near book, using a recovering earnings stream and excess capital to buy back a tenth of itself while paying a 4% yield to wait.
Bear Case
The structural truth a Truist holder has to sit with is that the stock is cheap for a reason: the bank does not yet earn what its capital base should command. It trades at only about 1.1x book, in the lower half of its peer group's price-to-book, because its return on equity has recently been around 8.6%, and paying roughly book value for a bank earning that return is the market saying it will believe the higher numbers when it sees them sustained. The price ultimately assumes a return on equity near 11.9%; the gap between that and the 8.3% the bank has recently earned is the entire bet. If that improvement stalls, there is no valuation cushion, because the price already sits close to what the value methods support rather than above it.
The reason returns have lagged is the same reason the discount persists. Truist is the product of a massive merger, and its GAAP equity carries heavy goodwill from that combination, which drags the reported return on equity below the tangible figure management prefers to quote. The bank is still proving it can convert its scale into peer-level profitability rather than merger-integration drag. Net interest margin is not helping in the near term: it compressed five basis points to 3.02% in Q1 2026 on elevated funding costs, and a bank whose margin is under pressure has to lean harder on volume and fees to grow earnings.
The credit backdrop is the risk the capital return could run into. The FY2025 10-K is explicit that Truist "may have higher credit risk, or experience higher credit losses, to the extent its loan exposures increase or are concentrated by loan type, industry segment, borrower type, or location," and it flags commercial loans rated "special mention or substandard performing" as monitored potential problem loans. Regional banks carry meaningful commercial real estate exposure, and a credit cycle would hit earnings and capital at the same time the bank is deliberately running CET1 down toward 10%. Returning more than the bank earns is fine while credit is benign; it looks different if charge-offs rise while the capital cushion is being spent on buybacks.
Valuation
A bank is priced off its book value and the return it earns on it. At $51.69 (July 11, 2026), Truist trades at about 1.1x its book value of $50.70 per share, and inverting the price says the market assumes a sustained return on equity of about 11.9%. The bank has recently been earning about 8.3% on that basis. That gap is the crux: the price needs the bank's profitability to climb meaningfully from where it sits, and while the assumed return is within reach of what Truist has earned in better periods, it is well above the current run rate. The stock sits in the lower half of its peer group's price-to-book precisely because the market is not yet paying for the higher return as a given.
The methods read the price as reasonable rather than stretched, which fits a value-supported name. The asset-based lens finds it modestly rich (about 1.2x tangible value), while the earnings-power, peer-multiple, and growth-oriented lenses all land at or below the price. This is a bank whose valuation rests on the book value being sound and the earnings gradually recovering toward peer levels, not on any growth premium. The distinction that matters is basis: management quotes return on tangible common equity of 13.8%, a respectable figure, but the GAAP return on total equity of about 8.6% is lower because merger goodwill inflates the equity base. A reader should hold both in view; the tangible figure shows the operating engine, the GAAP figure shows what the whole capital base earns.
Solvency for a bank is capital and payout, and here the story is a deliberate capital return. CET1 is 10.8%, above requirements, and management is spending the surplus down toward a 10% target by 2027, funding a 4% dividend and a raised $5 billion buyback plan for 2026. Liquidity is ample, with the 10-K reporting a "111%" liquidity coverage ratio against a 100% minimum. The price is not stretched against the methods; it is a bet that Truist lifts its return on equity toward the level the price assumes while it returns excess capital, with the risk that a credit downturn arrives while the cushion is being spent.
Catalysts
Q1 2026 showed earnings recovering and capital return accelerating. Truist reported net income available to common of $1.4 billion, or $1.09 per diluted share, up 25% year over year, with return on tangible common equity of 13.8%. Net interest margin slipped five basis points to 3.02% on elevated funding costs, the main near-term pressure on the earnings trajectory. The CET1 ratio held at 10.8%, unchanged from year-end.
The capital-return plan is the dominant forward story. Truist deployed about $1.8 billion in common dividends and buybacks during the quarter ($0.52 per-share dividend plus $1.1 billion of repurchases), and raised its 2026 buyback target to $5 billion from $4 billion, with a stated path toward a 10% CET1 level by 2027 that frees further capacity. The items to watch are whether net interest margin stabilizes or resumes expanding as funding costs ease, whether return on equity climbs toward the level the price assumes, credit-quality trends in the commercial and commercial-real-estate book, and the pace of buybacks against the CET1 drawdown. The next quarterly report is the immediate checkpoint on both the margin and the capital plan.
Peer Cohorts (Per Segment, With Filing Citations)
Consumer and Small Business Banking (CSBB) (reported)
- RF (Regions Financial Corporation)
- (no filing in the citation store)
- PNC (PNC FINANCIAL SERVICES GROUP, INC.)
- (no filing in the citation store)
- USB (US BANCORP \DE\)
- (no filing in the citation store)
- CFG (CITIZENS FINANCIAL GROUP INC/RI)
- (no filing in the citation store)
- FITB (Fifth Third Bancorp)
- (no filing in the citation store)
- KEY (KEYCORP /NEW/)
- (no filing in the citation store)
- HBAN (Huntington Bancshares Incorporated)
- (no filing in the citation store)
- MTB (M&T BANK CORPORATION)
- (no filing in the citation store)
Wholesale Banking (WB) (reported)
- PNC (PNC FINANCIAL SERVICES GROUP, INC.)
- (no filing in the citation store)
- USB (US BANCORP \DE\)
- (no filing in the citation store)
- MTB (M&T BANK CORPORATION)
- (no filing in the citation store)
- CFG (CITIZENS FINANCIAL GROUP INC/RI)
- (no filing in the citation store)
- FITB (Fifth Third Bancorp)
- (no filing in the citation store)
- KEY (KEYCORP /NEW/)
- (no filing in the citation store)
- RF (Regions Financial Corporation)
- (no filing in the citation store)
- HBAN (Huntington Bancshares Incorporated)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Q1 2026 earnings call · Q1 2026 earnings release